Filter:AllMonitoringDiagnosisComplicationsType 1Type 2
The FDA has authorized Libre Duo 10 Day for people aged 2 and older with diabetes. Here is how combined continuous glucose and ketone monitoring works, what the evidence shows, and the DKA safety limits patients should understand.
A 15,413-person real-world study linked publicly funded flash glucose monitoring with fewer acute diabetes-related hospitalizations, shorter stays, and lower inpatient costs, but its quasi-experimental design cannot prove that monitoring alone caused the improvements.
